Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma

Published:2017-11-06 Issue:2 Volume:7 Page:e1392427
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Cao Bangrong¹,Wang Qifeng²,Zhang Huan¹,Zhu Guiquan³^ORCID,Lang Jinyi²

Affiliation:

1. Department of Basic Research, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

2. Department of Radiation Oncology, and Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

3. Department of Head and Neck Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1392427

Reference46 articles.

1. Cancer statistics, 2017

2. Oral cavity and oropharyngeal squamous cell carcinoma-an update

3. Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

4. PD-1 Blockers

5. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focusing on tumor and it’s microenvironmental immune members for head and neck cancer patients;Pathology - Research and Practice;2024-11

2. Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods;Heliyon;2024-02

3. (-)-Epicatechin Attenuates Myocardial Fibrosis and Apoptosis by Suppressing the Transforming Growth Factor-β1 Pathway in Acute Myocardial Infarction;J BIOL REG HOMEOS AG;2023

4. Identification of Metabolism-Related Molecular Classifications of Gastric Cancer Based on Prognosis and Immune Infiltration;J BIOL REG HOMEOS AG;2023

5. 90 K increased delivery efficiency of extracellular vesicles through mediating internalization;Journal of Controlled Release;2023-01